Erschienen in:
01.03.2010
Leukocyte Adhesion Deficiency Type II: Long-Term Follow-Up and Review of the Literature
verfasst von:
Yael Gazit, Adi Mory, Amos Etzioni, Moshe Frydman, Oded Scheuerman, Ruth Gershoni-Baruch, Ben-Zion Garty
Erschienen in:
Journal of Clinical Immunology
|
Ausgabe 2/2010
Einloggen, um Zugang zu erhalten
Abstract
Introduction
Leukocyte adhesion deficiency (LAD) is a group of rare inherited disorders characterized by immune deficiency and peripheral neutrophilia. There are only seven reported cases of LAD type II worldwide, and no long-term follow-up data.
Case Report
We reviewed the medical file of a 20-year-old man with LAD II. Clinical characteristics included short stature, severe mental retardation, and autistic features. He had had no severe infections since infancy, and his current immunological status was stable. The last laboratory work-up revealed mild leukocytosis and neutrophilia. Genetic analysis of the Golgi GDP-fucose transporter (GFTP) sequence yielded a point mutation resulting in Y337C amino acid transition in the tenth transmembrane domain.
Conclusion
In conclusion, in LAD II, the main clinical countenance shifts from frequent infections due to immunodeficiency in the early years to the metabolic consequences of the defect in fucose metabolism, i.e., retarded growth and mental retardation, in the later years. A novel mutation in the GFTP loci associated with LAD II is described.